However, a surrogate assay based on inhibition of VLP binding to HBGA ligands has been used to demonstrate that virus-specific serum antibodies generated during experimental and natural infections neutralize carbohydrate binding [128,129,191,192]. The gene discussed is HBG1; the disease is infection.